Company Biomark Diagnostics Inc. Canadian Securities Exchange
Equities
BUX
CA09073K1084
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.24 CAD | 0.00% |
|
0.00% | -5.88% |
Business Summary
Sales per Business
CAD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Early-stage Cancer Diagnostic Technology Platform
100.0
%
| 0 | 100.0 % | 0 | 100.0 % | +249.38% |
Sales per region
CAD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Canada
100.0
%
| 0 | 100.0 % | 0 | 100.0 % | +249.38% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Rashid Maula Bux
FOU | Founder | - | 19/14/19 |
Guoyu Huang
DFI | Director of Finance/CFO | - | 15/17/15 |
Chief Tech/Sci/R&D Officer | - | 01/21/01 | |
Brian Cheng
CTO | Chief Tech/Sci/R&D Officer | - | 11/14/11 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Rashid Maula Bux
FOU | Founder | - | 19/14/19 |
Bram Ramjiawan
BRD | Director/Board Member | - | 11/14/11 |
Brian Cheng
CTO | Chief Tech/Sci/R&D Officer | - | 11/14/11 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 90,886,229 | 45,205,012 ( 49.74 %) | 0 | 49.74 % |
Company contact information
BioMark Diagnostics, Inc.
3851 Shell Road Suite 130
V6X 2W2, Richmond
+604 370 0779
http://www.biomarkdiagnostics.com![address Biomark Diagnostics Inc.(BUX)](https://cdn.zonebourse.com/static/address/33624625.png)
Sector
1st Jan change | Capi. | |
---|---|---|
-43.34% | 7.74B | |
+10.68% | 3.66B | |
-1.60% | 2.24B | |
-22.96% | 1.94B | |
-22.17% | 1.64B | |
+5.19% | 915M | |
+17.25% | 734M | |
-6.99% | 711M | |
-37.14% | 454M |
- Stock Market
- Equities
- 20B Stock
- BUX Stock
- Company Biomark Diagnostics Inc.